Advanced search
Publication Cover
Cancer Biology & Therapy Volume 20, 2019 - Issue 4
Submit an article Journal homepage
1,082
Views
6
CrossRef citations to date
0
Altmetric
Research Paper

Discovery platform for inhibitors of IgH gene enhancer activity

Nathan G. DolloffDepartment of Cellular and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USACorrespondence[email protected]
View further author information
Pages 571-581 | Received 28 Sep 2018, Accepted 16 Oct 2018, Published online: 27 Nov 2018

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Melissa Ferrad, Nour Ghazzaui, Hussein Issaoui, Emilie Drouineau, Christelle Oblet, Tiffany Marchiol, Jeanne Cook-Moreau & Yves Denizot. (2022) Homozygous iMycCα transgenic mice as a model of plasma B-cell lymphomas. Leukemia & Lymphoma 63:9, pages 2114-2125.
Read now

Articles from other publishers (5)

Arnold J. Levine, John D. Carpten, Maureen Murphy & Pierre Hainaut. (2023) Exploring the genetic and molecular basis of differences in multiple myeloma of individuals of African and European descent. Cell Death & Differentiation.
Crossref
Harini Hariharan, Saurav Panicker & Satish Ramalingam. 2023. Cancer Genes: Volume 2. Cancer Genes: Volume 2 19 61 .
Anna Y. Aksenova, Anna S. Zhuk, Artem G. Lada, Irina V. Zotova, Elena I. Stepchenkova, Ivan I. Kostroma, Sergey V. Gritsaev & Youri I. Pavlov. (2021) Genome Instability in Multiple Myeloma: Facts and Factors. Cancers 13:23, pages 5949.
Crossref
Marta Elżbieta Kasprzyk, Wojciech Łosiewski, Marta Podralska, Marta Kazimierska, Weronika Sura & Agnieszka Dzikiewicz-Krawczyk. (2021) 7-[[(4-methyl-2-pyridinyl)amino](2-pyridinyl)methyl]-8-quinolinol (compound 30666) inhibits enhancer activity and reduces B-cell lymphoma growth – A question of specificity. European Journal of Pharmacology 910, pages 174505.
Crossref
Marta Kasprzyk, Weronika Sura & Agnieszka Dzikiewicz-Krawczyk. (2021) Enhancing B-Cell Malignancies—On Repurposing Enhancer Activity towards Cancer. Cancers 13:13, pages 3270.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.